Back to News
Market Impact: 0.43

MYR Group (MYRG) Q1 2026 Earnings Transcript

MYRGNFLXNVDAGS
Corporate EarningsCorporate Guidance & OutlookCompany FundamentalsInfrastructure & DefenseCapital Returns (Dividends / Buybacks)M&A & RestructuringBanking & Liquidity

MYR Group posted record Q1 revenue of $1.0 billion, up 20%, with net income more than doubling to a record $47 million and EBITDA rising to a record $82 million. Management raised full-year margin targets to 6%-9% for C&I and 8%-11% for T&D, and lifted revenue growth outlook to about 12%, supported by a record $2.84 billion backlog and strong cash generation. The balance sheet remains very conservative with only $9 million of funded debt, $163 million of cash, and 0.04x funded debt-to-EBITDA, leaving room for capex, M&A, and buybacks.

Analysis

MYRG’s real signal is not the headline beat; it’s the mix shift toward recurring MSA work and the willingness to lock in higher contractual terms before the cycle fully tightens. That combination usually shows up first as better gross-to-operating conversion, then later as more visible pricing power once large utility transmission programs become bottlenecks rather than optional spend. The company is effectively turning balance-sheet capacity into a quasi-embedded call option on grid capex acceleration. The second-order effect is that the earnings quality is improving faster than the market likely appreciates: more prefab, better terms, and less first-in risk reduce field volatility and should compress the left-tail of margin outcomes. But that same MSA-heavy mix can temporarily mask working-capital drag, so reported cash generation may lag earnings for a few quarters if award timing pushes DSO higher. In other words, near-term optics could wobble while the underlying franchise becomes more durable. The key contrarian point is that consensus may still be underestimating how long this demand cycle can run, but also overestimating the immediacy of the margin re-rate. Large transmission projects look like a 2027+ revenue bridge, so the stock is vulnerable if investors pay up today for backlog that converts slowly. The better setup is a multi-quarter compounding story rather than a one-quarter squeeze: if execution stays clean, the market should eventually rerate MYRG on 2027 earnings power, not just 2026 guidance. Primary risks are a mix-induced DSO step-up, project-level inefficiencies, and timing slippage on large transmission awards; any one of those can create a temporary de-rating even if the medium-term thesis remains intact. The catalyst path is strong but uneven: next few quarters should show whether elevated margin targets are sustainable or just a favorable burn-off of older jobs. If new large awards convert into backlog faster than expected, this can reprice aggressively on revised 2027-2028 visibility.